Annual Cash & Cash Equivalents
$115.46 M
-$155.39 M-57.37%
December 31, 2024
Summary
- As of March 14, 2025, MURA annual cash & cash equivalents is $115.46 million, with the most recent change of -$155.39 million (-57.37%) on December 31, 2024.
- MURA annual cash & cash equivalents is now -57.37% below its all-time high of $270.85 million, reached on December 31, 2023.
Performance
MURA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$115.46 M
+$4.44 M+4.00%
December 31, 2024
Summary
- As of March 14, 2025, MURA quarterly cash and cash equivalents is $115.46 million, with the most recent change of +$4.44 million (+4.00%) on December 31, 2024.
- Over the past year, MURA quarterly cash and cash equivalents has dropped by -$155.39 million (-57.37%).
- MURA quarterly cash and cash equivalents is now -57.76% below its all-time high of $273.34 million, reached on June 30, 2023.
Performance
MURA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MURA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.4% | -57.4% |
| 3 y3 years | - | -57.8% |
| 5 y5 years | - | -57.8% |
MURA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.4% | -100.0% | -57.8% | -100.0% |
| 5 y | 5-year | -57.4% | -100.0% | -57.8% | -100.0% |
| alltime | all time | -57.4% | -100.0% | -57.8% | -100.0% |
Mural Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $115.46 M | $115.46 M(+4.0%) |
| Sep 2024 | - | $111.02 M(-8.7%) |
| Jun 2024 | - | $121.59 M(+13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $107.26 M(-60.4%) |
| Dec 2023 | $270.85 M(>+9900.0%) | $270.85 M(-0.9%) |
| Jun 2023 | - | $273.34 M(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00 |
FAQ
- What is Mural Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mural Oncology?
- What is Mural Oncology annual cash & cash equivalents year-on-year change?
- What is Mural Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mural Oncology?
- What is Mural Oncology quarterly cash and cash equivalents year-on-year change?
What is Mural Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of MURA is $115.46 M
What is the all time high annual cash & cash equivalents for Mural Oncology?
Mural Oncology all-time high annual cash & cash equivalents is $270.85 M
What is Mural Oncology annual cash & cash equivalents year-on-year change?
Over the past year, MURA annual cash & cash equivalents has changed by -$155.39 M (-57.37%)
What is Mural Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MURA is $115.46 M
What is the all time high quarterly cash and cash equivalents for Mural Oncology?
Mural Oncology all-time high quarterly cash and cash equivalents is $273.34 M
What is Mural Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, MURA quarterly cash and cash equivalents has changed by -$155.39 M (-57.37%)